Mereo BioPharma (MREO)

• Market cap: $337M
• 1 day: -3.56%
• 5 days: -7.66%
• 1 month: -6.47%
• 3 months: -36.55%
• 6 months: -47.96%
• Year to date: -36.55%
• 1 year: -36.36%
• 5 years: 110.68%
• 10 years: -66.62%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

65% more call options, than puts

Call options by funds: $3.02M | Put options by funds: $1.84M

17% more funds holding

Funds holding: 77 [Q3] → 90 (+13) [Q4]

1.1% more ownership

Funds ownership: 13.75% [Q3] → 14.85% (+1.1%) [Q4]

7% less capital invested

Capital invested by funds: $435M [Q3] → $403M (-$31.7M) [Q4]

30% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 27

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $7 223% upside
• Avg. target: $7 223% upside
• High target: $7 223% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

JP Morgan Priyanka Grover 0% 1-year accuracy 0 / 1 met price target	223% upside $7	Overweight Initiated	27 Mar 2025
Needham Gil Blum 7% 1-year accuracy 11 / 161 met price target	223% upside $7	Buy Reiterated	26 Mar 2025
Cantor Fitzgerald Kristen Kluska 30% 1-year accuracy 32 / 108 met price target	223% upside $7	Overweight Reiterated	18 Mar 2025